Enantioselective liquid chromatography-mass spectrometry assay for the determination of ifosfamide and identification of the N-dechloroethylated metabolites of ifosfamide in human plasma.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Pharmaceutical and Biomedical Analysis

• Publication date

  2007-10-18

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.JPBA.2007.07.026PMID 17855037PMCID PMC2083559
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stereoselective pharmacokinetics of ifosfamide and its 2- and 3-N-dechloroethylated metabolites in female cancer patients

  2009cited by this paper
• The effect of route of administration and fractionation of dose on the metabolism of ifosfamide

  2008cited by this paper
• Enantioselective metabolism of ifosfamide by the kidney.

  2006cited by this paper
• PII‐80

  2006cited by this paper
• ENANTIOSELECTIVE METABOLISM AND CYTOTOXICITY OF R-IFOSFAMIDE AND S-IFOSFAMIDE BY TUMOR CELL-EXPRESSED CYTOCHROMES P450

  2005cited by this paper
• Metabolism and Transport of Oxazaphosphorines and the Clinical Implications

  2005cited by this paper
• Liquid chromatography-mass spectrometry assay for quantitation of ifosfamide and its N-deschloroethylated metabolites in rat microsomal medium.

  2005cited by this paper
• Feasibility of chemosensitivity testing in soft tissue sarcomas

  2005cited by this paper
• Core biopsy as a tool in planning the management of invasive breast cancer

  2005cited by this paper
• Ifosfamide pharmacokinetics

  2004cited by this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Ifosfamide and its Metabolites

  2001cited by this paper
• Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites.

  2000cited by this paper
• Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: A report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94

  1999cited by this paper
• Stereoselective metabolism of ifosfamide by human P-450s 3A4 and 2B6. Favorable metabolic properties of R-enantiomer.

  1999cited by this paper
• Determination of ifosfamide by HPLC using on-line sample preparation.

  1999cited by this paper
• Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)- and (S)-ifosfamide in human liver microsomes.

  1999cited by this paper
• Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology.

  1997cited by this paper
• Chromatographic analysis of the enantiomers of ifosfamide and some of its metabolites in plasma and urine.

  1997cited by this paper
• The N-dechloroethylation of ifosfamide: using stereochemistry to obtain an accurate picture of a clinically relevant metabolic pathway

  1996cited by this paper
• A covalently bonded teicoplanin chiral stationary phase for HPLC enantioseparations

  1995cited by this paper
• Ifosfamide stereoselective dichloroethylation and neurotoxicity.

  1994cited by this paper
• Enantiomeric separation of R- and S-ifosfamide and their determination in serum from clinical subjects.

  1994cited by this paper
• Determination of the enantiomers of ifosfamide and its 2- and 3-N-dechloroethylated metabolites in plasma and urine using enantioselective gas chromatography with mass spectrometric detection.

  1993cited by this paper
• Analytical and preparative high-performance liquid chromatographic separation of the enantiomers of ifosfamide, cyclophosphamide and trofosfamide and their determination in plasma.

  1989cited by this paper
• The determination of (-)-(S)- and (+)-(R)-ifosfamide in plasma using enantioselective gas chromatography: a validated assay for pharmacokinetic and clinical studies.

  1989cited by this paper
• Practical HPLC method development

  1988cited by this paper
• Gaschromatographische Bestimmung und Enantiomerentrennung von Ifosfamid sowie der Metaboliten 2‐ und 3‐Deschlorethylifosfamid. Gas‐Chromatographic Determination and Enantiomer Separation of Ifosfamide and Its Metabolites 2‐and 3‐De(chloroethyl)ifosfamide

  1986cited by this paper
• Chromatographic Resolution of Chiral Drugs on Polyamides and Cellulose Triacetate

  1986cited by this paper
• Dechloroethylation of ifosfamide and neurotoxicity.

  1986cited by this paper
• Ifosfamide--pharmacology, safety and therapeutic potential.

  1985cited by this paper
• Frederick Ronald Chistopher Casson.

  1975cited by this paper
• [New drugs. 9].

  1973cited by this paper

• Selected Ion Monitoring Using Low-Cost Mass Spectrum Detectors Provides a Rapid, General, and Accurate Method for Enantiomeric Excess Determination in High-Throughput Experimentation.

  2022cites this paper
• Antineoplastic drugs and their analysis: a state of the art review.

  2017cites this paper
• Inorganic nanolayers: structure, preparation, and biomedical applications

  2015cites this paper
• Preactivated oxazaphosphorines designed for isophosphoramide mustard delivery as bulk form or nanoassemblies: synthesis and proof of concept.

  2015cites this paper
• Enantioseparation of chiral pharmaceuticals in biomedical and environmental analyses by liquid chromatography: an overview.

  2014cites this paper
• Enantioselectivity of mass spectrometry: challenges and promises.

  2013cites this paper
• Disposição cinética dos enantiômeros da ifosfamida em pacientes portadoras de câncer de colo do útero

  2013cites this paper
• Review: Recent application of chiral liquid chromatography-tandem mass spectrometric methods for enantiomeric pharmaceutical and biomedical determinations.

  2013cites this paper
• Synthesis and Characterization of Ifosfamide Intercalated Layered Double Hydroxides

  2012cites this paper
• Therapeutic drug monitoring and LC-MS/MS.

  2012cites this paper
• Liquid chromatography-tandem mass spectrometry method for simultaneous determination of seven commonly used anticancer drugs in human plasma.

  2012cites this paper
• A molecular model of the enantioselective liquid chromatographic separation of (R,S)-ifosfamide and its N-dechloroethylated metabolites on a teicoplanin aglycon chiral stationary phase.

  2012cites this paper
• Analysis of anticancer drugs: a review.

  2011cites this paper
• Quantification of dimethyl-ifosfamide and its N-deschloropropylated metabolites in mouse plasma by liquid chromatography-tandem mass spectrometry.

  2011cites this paper
• Method Development Strategy and Applications Update for CHIROBIOTIC Chiral Stationary Phases

  2009cites this paper
• Chiral separations.

  2008cites this paper
• Applications of LC-MS to quantitation and evaluation of the environmental fate of chiral drugs and their metabolites

  2008cites this paper
• The Nitrogen Mustards

  1951cites this paper